Merck to Present New Data from Various HIV Research and Development Programs at CROI 2021
Search jobs Merck to Present New Data from Various HIV Research and Development Programs at CROI 2021 KENILWORTH, N.J.--(BUSINESS WIRE)--$MRK#MRK--Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced today upcoming presentations from its HIV clinical development programs that will be featured during the 2021 Conference on Retroviruses and Opportunistic Infections (CROI 2021), taking place virtually from March 6 – 10, 2021. Presentations will include new data for islatravir, the company’s investigational nucleoside reverse transcriptase t...
Source: pharmiweb.com